Altrumed LLC
Philadelphia, PA
- UEI
- J8F3W4SWZ944
- CAGE
- 94GQ7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3401 Grays Ferry Ave Bldg 450 Ste 1067, Philadelphia, PA 19146, USA
- Website
- altru-med.com
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Responding to the opioid crisis with dove: a standalone opioid overdose detection and alert device - abstract /… | National Institute on Drug Abuse | $403,307 | |
| Device-agnostic hypoxia detection software for overdose prediction and positive reversal monitoring - abstract / project… | National Institute on Drug Abuse | $808,156 | |
| The dove device to prevent opioid overdose deaths: an armband that senses overdose and automatically injects naloxone… | National Institute on Drug Abuse | $1,114,692 |
About Altrumed LLC
Altrumed LLC is a for-profit limited liability company registered in SAM.gov, located in Philadelphia, Pennsylvania, with a current registration valid through November 30, 2025. The company appears to be focused on developing innovative medical technology solutions, specifically targeting opioid overdose prevention and detection through advanced wearable sensor systems. While limited public information is available about the company's comprehensive background, its primary focus seems to be on developing technological interventions to address critical healthcare challenges related to opioid use and overdose prevention.
Altrumed LLC has received federal grant awards from the National Institute on Drug Abuse (NIDA) to develop the DOVE device, an advanced wearable sensor system designed to detect and respond to potential opioid overdoses. The company has been awarded two significant project grants totaling $404,078, with award periods spanning from May 2023 to July 2026. The DOVE device is a sophisticated armband that uses pulse oximetry and accelerometry to monitor respiratory patterns, detect potential overdoses, and provide real-time interventional guidance. The project involves collaborative partnerships with research institutions such as Children's Research Institute and The Children's Hospital of Philadelphia, which have provided sub-awards to support device optimization, validation, and patient interaction testing. The grants focus on creating a device-agnostic solution that can predict fatal overdoses, automatically guide responders, and potentially administer naloxone or facilitate bag-valve-mask ventilation, addressing the critical challenge of rapid intervention during opioid-induced respiratory depression.
Quick answers
What is Altrumed LLC's UEI?
Altrumed LLC's Unique Entity ID (UEI) in SAM.gov is J8F3W4SWZ944.
What is Altrumed LLC's CAGE code?
Altrumed LLC's CAGE code is 94GQ7.
What is Altrumed LLC's primary NAICS code?
Altrumed LLC's primary NAICS code is 621999 (All Other Miscellaneous Ambulatory Health Care Services).
Where is Altrumed LLC located?
Altrumed LLC's physical address in SAM.gov is 3401 Grays Ferry Ave Bldg 450 Ste 1067, Philadelphia, PA 19146, USA.
Is Altrumed LLC registered in SAM.gov?
Yes. Altrumed LLC's SAM.gov registration is active through December 8, 2026.
What is Altrumed LLC's most recent federal award?
Altrumed LLC's most recent federal grant award is Responding to the opioid crisis with dove: a standalone opioid overdose detection and alert device - abstract /… (R44DA063251), from National Institute on Drug Abuse, on September 1, 2026.
On GovTribe
See Altrumed LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors